Danaher Corporation is considered a top long-term investment, but was downgraded by Rothschild & Co. due to premium valuation and lower growth outlook. The company specializes in life sciences and diagnostics, offering products and services for biological medicines.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing